Diversity, Equity, Inclusion and Accessibility
Following the murder of George Floyd in June 2020, I like many others, felt an extreme urgency to get more involved in Diversity, Equity, Inclusion, and Justice (DEIJ) in all aspects of life. I marched for BLM in Boston. I began educating myself on how to be actively anti-racist. I learned more about institutional racism and realized how under-utilized my power and privilege were in disassembling it. I have always supported, cultivated, and appreciated the immense value of a diverse lab environment, not just because it is the righteous thing to do but because it brings new perspectives, a wider range of ideas, and begets a more interesting and welcoming work environment and yes, better science. Like many others, the “EIJ” of DEIJ has been a knowledge gap for me as I continue to learn how to provide an environment that is not just more diverse, but also more Equitable, Inclusive, and Just. There is a useful analogy from one of the DEIJ workshops I recently attended: “’Diversity’ is being invited to the party, ‘Inclusion’ is being asked to dance at the party and choose the music; ‘Equity’ is getting equal time and space in the DJ booth or on the dance floor”. I think about this analogy frequently as I strive to make an inclusive work environment. We need to be vigilant and INTENTIONAL (not passive) in fostering equity and inclusion. I place an extremely high value on JUSTICE part of DEIJ and is a major motivator for me in my efforts. I want trainees at all levels and in every program to know that I am an active, approachable, and dedicated ally who will take them seriously and who will act when necessary and do all I can to see that barriers are removed for creating a safer, positive, and thriving environment. Doing the right thing at the right time in the face of risk (retribution, retaliation) is incredibly difficult but is absolutely necessary to produce measurable, persistent change from top-down. There must be consequences for those in power whose actions and environment they cultivate work against a more DEIJ environment. I have the utmost respect for faculty and administrators who dedicate their invisible, unmeasured time to DEIJ efforts, many of whom are people of color and from underrepresented backgrounds. I also have the utmost respect for the brave trainees who risk their careers to call out bad behaviors, e.g., racism, sexism, homophobia, bullying, psychological abuse, microaggressions, and sexual misconduct. I will continue to listen to their voices and I will continue to act on their concerns with swiftness and intention.
I joined Graduate Program for Neuroscience (GPN) DEIJ committee in June 2020 and remain an active faculty member. We have accomplished several goals over the past two years, including a seminar series “Stress, Resilience, and Society”, where we hosted neuroscientist speakers whose talks addressed behavioral and neurological correlates of stress and its transmission across generations. A GPN student would host each speaker and helped lead post-seminar discussions between the speakers and the PhD students on research in the context of DEIJ and society. During the second year, we organized a symposium on Neuroscience and Society and had a panel of speakers who covered topics such as empathy and sex differences in neuroscience research and an engaging panel discussion. We also applied for the opportunity to offer a merit-based endowed scholarship for an Emerging Scholars award for GPN (we are resubmitting this year). The goal of the scholarship is to recruit exceptional students coming from a socioeconomically disadvantaged background and who might not otherwise enroll in GPN (moving to Boston is very expensive) by providing financial support to offset prohibitive moving and living expenses, facilitate professional development, and ease funding barriers for lab entry. Student members successfully installed a local chapter for the Society for the Advancement of Chicanos/Hispanics and Native Americans (SACNAS). GPN DEIJ members like myself serve on the Admissions Committee and have created a general trajectory of increasing diversity with each new cohort of trainees.
Promoting DEIJ must begin early within the educational system. As a faculty member at a major R1 research university, I participate in training at multiple levels of education, including high school summer trainees, undergraduate researchers, graduate students (masters and PhD), and medical students. I prioritize supporting work-study undergraduates as they are frequently from underrepresented and disadvantaged backgrounds and receive monetary compensation for their work. I also mentor students from a variety of programs that support diversity, including BU Research In Science and Engineering (RISE) program for high school students, BU Summer Training As Research Scholars (STARS) program (NIH/NHLBI), and BU Post-Baccalaureate Research Education Program (PREP) program (NIH/NIGMS). I meet formally with trainees, discuss journal articles, review/advise on presentations, and review PhD application materials. I invite trainees to attend scientific meetings where I introduce them to my colleagues and encourage them to network and participate in career development workshops. I strive to provide as many opportunities as possible and to advocate for trainees at local, national, and international scientific meetings. I also participate in the national NIH/NIDA Summer Scholars program for undergraduate researchers from underrepresented and disadvantaged backgrounds, most of whom have earned authorship on published scientific papers.
I am a member of the Admissions Committee for the PhD program in Biomolecular Pharmacology and the Graduate Program for Neuroscience at Boston University. I also serve on the Selection Committee for the T32 Biomolecular Pharmacology PhD program where we prioritize diversity and look for students who are actively involved in outreach, DEIJ activities, and show genuine interest in helping their colleagues succeed. I attended a workshop on developing a rubric for assessment of applications, with the goal of minimizing selection bias that works against DEIJ efforts. In addition to considering defined rubrics and procedures, we pay special attention to students from disadvantaged and underrepresented backgrounds. We read personal statements carefully and do not go by rigid, arbitrary cut-offs such as GPA in making invitation decisions. We identify applicants who have overcome adversity and struggles in challenging situations and environments outside of their academic experience that has impeded their ability to otherwise flourish. We look for signs of improvement over time. We look closely at letters of recommendation that often add a different perspective and enrich our understanding of the applicant’s circumstances. This more careful, tedious approach has led us to consistently recruit a diverse lot of highly successful students.
Institutional racism directly impedes DEIJ and combating it from top-down can lead to substantial improvements in the work environment; however, there must be increased effort from the bottom-up early on to provide advantages and opportunities to level the playing field. I will continue to promote diversity in student and faculty recruitment in the committees on which I serve. I will continue to promote equity and inclusion and advocate for my trainees in my laboratory environment, at scientific conferences, meetings, and local events. I will continue to be actively involved in outreach, including visiting and speaking with students at HBUs and participating in career development workshops at NIH and scientific meetings. I chair multiple thesis committees for PhD students from underrepresented backgrounds and tend to their individual circumstances to make sure they succeed at the highest level. Actively promoting a DEIJ environment requires a constant self-awareness and re-evaluation, vigilance across all academic settings, and continual self-education and training. I will continue to educate myself and provide a DEIJ environment that is safe and welcoming. I will support and advocate for my students and others whom I serve so they can thrive at their full potential in their PhD programs and will arm trainees with the skills and opportunities needed to realize their most aspirational career goals.
This tab shows grant data from BMC Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from BU Sponsored Research. It includes:
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data that did not automatically get imported into Profiles
from BU or BMC sources.
- Grant title
- Project period and this person’s role on the grant
- PI name, if this person is not the PI (the name will link if PI has a BU Profile)
- Funding source(s). An arrow indicates the flow of funding if multiple sponsors.
- Some grants will show an agency award/project number, and may be a link.
- Data is sorted by project end date, and updated monthly.
This tab shows grant data from the Boston VA. We are only showing grant title, and only for people in the role of PI.
Systems genetics of premorbid and cocaine use traits in a rat reduced complexity cross05/01/2022 - 02/28/2027 (Multi-PI)
PI:
Camron D. Bryant, PhDNIH/National Institute on Drug Abuse5U01DA055299-02
The role of Zhx2 in CYP2D regulation, oxycodone metabolism, and opioid addiction model behaviors08/08/2023 - 07/31/2026 (Key Person / Mentor)
NIH/National Institute on Drug Abuse5F31DA056217-02
A Reduced Complexity Cross in BALB/c substrains to identify the genetic basis of oxycodone dependence phenotypes09/01/2020 - 06/30/2024 (Multi-PI)
PI:
Camron D. Bryant, PhDNIH/National Institute on Drug Abuse5U01DA050243-04
Genetic Basis of Chemotherapy-Induced Neuropathy in a Reduced Complexity Cross02/07/2018 - 01/31/2023 (Multi-PI)
PI:
Camron D. Bryant, PhDVirginia Commonwealth University NIH NCI5R01CA221260-04
Bridging genetic variation with behavior: Molecular and functional mechanisms of quantitative trait gene regulation of the stimulant and addictive properties of methamphetamine in mice07/01/2015 - 06/30/2022 (PI)
NIH/National Institute on Drug Abuse5R01DA039168-05
Overall NIDA Core "Center of Excellence" in Transcriptomics, Systems Genetics and the Addictome08/01/2019 - 10/31/2020 (Subcontract PI)
The University of Tennessee on behalf of its Health Science Center NIH NIDA5P30DA044223-03
Big Data Computational Methods for Analysis of Drugs of Abuse09/01/2017 - 06/30/2020 (Subcontract PI)
The Leland Stanford Junior University NIH NIDA5U01DA044399-03
Genetic basis of binge eating and its motivational components in a reduced complexity cross09/15/2015 - 08/31/2018 (PI)
NIH/National Institute on Drug Abuse5R21DA038738-02
Mapping G x E Interactions for Addiction Traits in a Reduced Complexity Cross07/01/2014 - 06/30/2017 (PI)
NIH/National Institute on Drug Abuse5R03DA038287-02
Bridging Genetic Variation with Behavior: Molecular and Functional Mechanisms.05/01/2015 - 04/30/2017 (PI)
NIH/National Institute on Drug Abuse3R00DA029635-05S2
Showing 10 of 11 results.
Show All Results
Genetic Basis of Opioid Reward and Aversion in Mice05/01/2013 - 04/30/2017 (PI)
NIH/National Institute on Drug Abuse5R00DA029635-05S1
Showing 10 of 32 results.
Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other
sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
-
Borrelli KN, Wingfield KK, Yao EJ, Zamorano CA, Sena KD, Beierle JA, Roos MA, Zhang H, Wachman EM, Bryant CD. Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice. Neuropharmacology. 2023 Dec 01; 240:109732.View Related Profiles. PMID: 37774943; PMCID: PMC10598517; DOI: 10.1016/j.neuropharm.2023.109732;
-
Borrelli KN, Wingfield KK, Yao EJ, Zamorano CA, Sena KD, Beierle JA, Roos MA, Zhang H, Wachman EM, Bryant CD. Decreased myelin-related gene expression in the nucleus accumbens during spontaneous neonatal opioid withdrawal in the absence of long-term behavioral effects in adult outbred CFW mice. bioRxiv. 2023 Aug 07.View Related Profiles. PMID: 37609129; PMCID: PMC10441327; DOI: 10.1101/2023.08.04.552033;
-
Parisien M, van Reij RRI, Khoury S, Koseli E, Karaky M, van den Hoogen NJ, Peng G, Allegri M, de Gregori M, Chelly JE, Rakel BA, Aasvang EK, Kehlet H, Buhre WFFA, Bryant CD, Damaj MI, King IL, Mogil JS, Joosten EAJ, Diatchenko L. Genome-wide association study suggests a critical contribution of the adaptive immune system to chronic post-surgical pain. medRxiv. 2023 Mar 10. PMID: 36945481; PMCID: PMC10029026; DOI: 10.1101/2023.01.24.23284520;
-
Parisien M, van Reij RRI, Khoury S, Koseli E, Karaky M, van den Hoogen NJ, Peng G, Allegri M, de Gregori M, Chelly JE, Rakel BA, Aasvang EK, Kehlet H, Buhre WFFA, Bryant CD, Damaj MI, King IL, Mogil JS, Joosten EAJ, Diatchenko L. Genome-wide association study suggests a critical contribution of the adaptive immune system to chronic post-surgical pain. medRxiv. 2023 Mar 10. PMID: 36945481; PMCID: PMC10029026; DOI: 10.1101/2023.01.24.23284520;
-
Ulker E, Caillaud M, Koseli E, Contreras K, Alkhlaif Y, Lindley E, Barik M, Ghani S, Bryant CD, Imad Damaj M. Comparison of Pain-Like behaviors in two surgical incision animal models in C57BL/6J mice. Neurobiol Pain. 2022; 12:100103. PMID: 36531613; PMCID: PMC9755018; DOI: 10.1016/j.ynpai.2022.100103;
-
-
Beierle JA, Yao EJ, Goldstein SI, Lynch WB, Scotellaro JL, Shah AA, Sena KD, Wong AL, Linnertz CL, Averin O, Moody DE, Reilly CA, Peltz G, Emili A, Ferris MT, Bryant CD. Zhx2 Is a Candidate Gene Underlying Oxymorphone Metabolite Brain Concentration Associated with State-Dependent Oxycodone Reward. J Pharmacol Exp Ther. 2022 Aug; 382(2):167-180.View Related Profiles. PMID: 35688478; PMCID: PMC9341249; DOI: 10.1124/jpet.122.001217;
-
-
-
Bulik CM, Coleman JRI, Hardaway JA, Breithaupt L, Watson HJ, Bryant CD, Breen G. Genetics and neurobiology of eating disorders. Nat Neurosci. 2022 May; 25(5):543-554. PMID: 35524137; PMCID: PMC9744360; DOI: 10.1038/s41593-022-01071-z;
Showing 10 of 64 results.
Show More
-
Beierle JA, Yao EJ, Goldstein SI, Scotellaro JL, Sena KD, Linnertz CA, Willits AB, Kader L, Young EE, Peltz G, Emili A, Ferris MT, Bryant CD. Genetic basis of thermal nociceptive sensitivity and brain weight in a BALB/c reduced complexity cross. Mol Pain. 2022 Jan-Dec; 18:17448069221079540.View Related Profiles. PMID: 35088629; PMCID: PMC8891926; DOI: 10.1177/17448069221079540;
-
Goldberg LR, Yao EJ, Kelliher JC, Reed ER, Wu Cox J, Parks C, Kirkpatrick SL, Beierle JA, Chen MM, Johnson WE, Homanics GE, Williams RW, Bryant CD, Mulligan MK. A quantitative trait variant in Gabra2 underlies increased methamphetamine stimulant sensitivity. Genes Brain Behav. 2021 11; 20(8):e12774.View Related Profiles. PMID: 34677900; PMCID: PMC9083095; DOI: 10.1111/gbb.12774;
-
Borrelli KN, Yao EJ, Yen WW, Phadke RA, Ruan QT, Chen MM, Kelliher JC, Langan CR, Scotellaro JL, Babbs RK, Beierle JC, Logan RW, Johnson WE, Wachman EM, Cruz-Martín A, Bryant CD. Sex Differences in Behavioral and Brainstem Transcriptomic Neuroadaptations following Neonatal Opioid Exposure in Outbred Mice. eNeuro. 2021 Sep-Oct; 8(5).View Related Profiles. PMID: 34479978; PMCID: PMC8454922; DOI: 10.1523/ENEURO.0143-21.2021;
-
Warncke UO, Toma W, Meade JA, Park AJ, Thompson DC, Caillaud M, Bigbee JW, Bryant CD, Damaj MI. Impact of Dose, Sex, and Strain on Oxaliplatin-Induced Peripheral Neuropathy in Mice. Front Pain Res (Lausanne). 2021; 2:683168. PMID: 35295533; PMCID: PMC8915759; DOI: 10.3389/fpain.2021.683168;
-
Kantak KM, Stots C, Mathieson E, Bryant CD. Spontaneously Hypertensive Rat substrains show differences in model traits for addiction risk and cocaine self-administration: Implications for a novel rat reduced complexity cross. Behav Brain Res. 2021 08 06; 411:113406.View Related Profiles. PMID: 34097899; PMCID: PMC8265396; DOI: 10.1016/j.bbr.2021.113406;
-
Jimenez Chavez CL, Bryant CD, Munn-Chernoff MA, Szumlinski KK. Selective Inhibition of PDE4B Reduces Binge Drinking in Two C57BL/6 Substrains. Int J Mol Sci. 2021 May 21; 22(11). PMID: 34064099; PMCID: PMC8196757; DOI: 10.3390/ijms22115443;
-
Yao EJ, Babbs RK, Kelliher JC, Luttik KP, Borrelli KN, Damaj MI, Mulligan MK, Bryant CD. Systems genetic analysis of binge-like eating in a C57BL/6J x DBA/2J-F2 cross. Genes Brain Behav. 2021 May 12; e12751.View Related Profiles. PMID: 33978997; PMCID: PMC9361732; DOI: 10.1111/gbb.12751;
-
Borrelli KN, Langan CR, Dubinsky KR, Szumlinski KK, Carlezon WA, Chartoff EH, Bryant CD. Intracranial self-stimulation and concomitant behaviors following systemic methamphetamine administration in Hnrnph1 mutant mice. Psychopharmacology (Berl). 2021 Jul; 238(7):2031-2041.View Related Profiles. PMID: 33758972; PMCID: PMC8715365; DOI: 10.1007/s00213-021-05829-4;
-
-
Bryant CD, Healy AF, Ruan QT, Coehlo MA, Lustig E, Yazdani N, Luttik KP, Tran T, Swancy I, Brewin LW, Chen MM, Szumlinski KK. Sex-dependent effects of an Hnrnph1 mutation on fentanyl addiction-relevant behaviors but not antinociception in mice. Genes Brain Behav. 2021 03; 20(3):e12711.View Related Profiles. PMID: 33145940
-
Shab G, Fultz EK, Page A, Coelho MA, Brewin LW, Stailey N, Brown CN, Bryant CD, Kippin TE, Szumlinski KK. The motivational valence of methamphetamine relates inversely to subsequent methamphetamine self-administration in female C57BL/6J mice. Behav Brain Res. 2021 02 01; 398:112959. PMID: 33053382; PMCID: PMC7722188; DOI: 10.1016/j.bbr.2020.112959;
-
Pourhaghighi R, Ash PEA, Phanse S, Goebels F, Hu LZM, Chen S, Zhang Y, Wierbowski SD, Boudeau S, Moutaoufik MT, Malty RH, Malolepsza E, Tsafou K, Nathan A, Cromar G, Guo H, Al Abdullatif A, Apicco DJ, Becker LA, Gitler AD, Pulst SM, Youssef A, Hekman R, Havugimana PC, White CA, Blum BC, Ratti A, Bryant CD, Parkinson J, Lage K, Babu M, Yu H, Bader GD, Wolozin B, Emili A. BraInMap Elucidates the Macromolecular Connectivity Landscape of Mammalian Brain. Cell Syst. 2020 Aug 26; 11(2):208.View Related Profiles. PMID: 32853540
-
Wachman EM, Wang A, Isley BC, Boateng J, Beierle JA, Hansbury A, Shrestha H, Bryant C, Zhang H. Placental OPRM1 DNA methylation and associations with neonatal opioid withdrawal syndrome, a pilot study. Explor Med. 2020 Jun; 1(3):124-135.View Related Profiles. PMID: 33763662; PMCID: PMC7985727; DOI: 10.37349/emed.2020.00009;
-
-
Ulker E, Caillaud M, Patel T, White A, Rashid D, Alqasem M, Lichtman AH, Bryant CD, Damaj MI. C57BL/6 substrain differences in formalin-induced pain-like behavioral responses. Behav Brain Res. 2020 07 15; 390:112698. PMID: 32428630; PMCID: PMC7375808; DOI: 10.1016/j.bbr.2020.112698;
-
Ruan QT, Yazdani N, Reed ER, Beierle JA, Peterson LP, Luttik KP, Szumlinski KK, Johnson WE, Ash PEA, Wolozin B, Bryant CD. 5' UTR variants in the quantitative trait gene Hnrnph1 support reduced 5' UTR usage and hnRNP H protein as a molecular mechanism underlying reduced methamphetamine sensitivity. FASEB J. 2020 07; 34(7):9223-9244.View Related Profiles. PMID: 32401417; PMCID: PMC8006537; DOI: 10.1096/fj.202000092R;
-
Pourhaghighi R, Ash PEA, Phanse S, Goebels F, Hu LZM, Chen S, Zhang Y, Wierbowski SD, Boudeau S, Moutaoufik MT, Malty RH, Malolepsza E, Tsafou K, Nathan A, Cromar G, Guo H, Abdullatif AA, Apicco DJ, Becker LA, Gitler AD, Pulst SM, Youssef A, Hekman R, Havugimana PC, White CA, Blum BC, Ratti A, Bryant CD, Parkinson J, Lage K, Babu M, Yu H, Bader GD, Wolozin B, Emili A. BraInMap Elucidates the Macromolecular Connectivity Landscape of Mammalian Brain. Cell Syst. 2020 04 22; 10(4):333-350.e14.View Related Profiles. PMID: 32325033; PMCID: PMC7938770; DOI: 10.1016/j.cels.2020.03.003;
-
Babbs RK, Beierle JA, Yao EJ, Kelliher JC, Medeiros AR, Anandakumar J, Shah AA, Chen MM, Johnson WE, Bryant CD. The effect of the demyelinating agent cuprizone on binge-like eating of sweetened palatable food in female and male C57BL/6 substrains. Appetite. 2020 07 01; 150:104678.View Related Profiles. PMID: 32209386; PMCID: PMC7206526; DOI: 10.1016/j.appet.2020.104678;
-
Brown CN, Fultz EK, Ferdousian S, Rogers S, Lustig E, Page A, Shahin JR, Flaherty DM, Von Jonquieres G, Bryant CD, Kippin TE, Szumlinski KK. Transgenic Analyses of Homer2 Function Within Nucleus Accumbens Subregions in the Regulation of Methamphetamine Reward and Reinforcement in Mice. Front Psychiatry. 2020; 11:11. PMID: 32116834; PMCID: PMC7013000; DOI: 10.3389/fpsyt.2020.00011;
-
Sern KR, Fultz EK, Coelho MA, Bryant CD, Szumlinski KK. A prior history of binge-drinking increases sensitivity to the motivational valence of methamphetamine in female C57BL/6J mice. Subst Abuse. 2020; 14:1178221819897073. PMID: 32009790; PMCID: PMC6971957; DOI: 10.1177/1178221819897073;
-
Ruan QT, Yazdani N, Blum BC, Beierle JA, Lin W, Coelho MA, Fultz EK, Healy AF, Shahin JR, Kandola AK, Luttik KP, Zheng K, Smith NJ, Cheung J, Mortazavi F, Apicco DJ, Ragu Varman D, Ramamoorthy S, Ash PEA, Rosene DL, Emili A, Wolozin B, Szumlinski KK, Bryant CD. A Mutation in Hnrnph1 That Decreases Methamphetamine-Induced Reinforcement, Reward, and Dopamine Release and Increases Synaptosomal hnRNP H and Mitochondrial Proteins. J Neurosci. 2020 01 02; 40(1):107-130.View Related Profiles. PMID: 31704785; PMCID: PMC6939476; DOI: 10.1523/JNEUROSCI.1808-19.2019;
-
Babbs RK, Beierle JA, Ruan QT, Kelliher JC, Chen MM, Feng AX, Kirkpatrick SL, Benitez FA, Rodriguez FA, Pierre JJ, Anandakumar J, Kumar V, Mulligan MK, Bryant CD. Cyfip1 Haploinsufficiency Increases Compulsive-Like Behavior and Modulates Palatable Food Intake in Mice: Dependence on Cyfip2 Genetic Background, Parent-of Origin, and Sex. G3 (Bethesda). 2019 09 04; 9(9):3009-3022.View Related Profiles. PMID: 31324746; PMCID: PMC6723122; DOI: 10.1534/g3.119.400470;
-
Mulligan MK, Abreo T, Neuner SM, Parks C, Watkins CE, Houseal MT, Shapaker TM, Hook M, Tan H, Wang X, Ingels J, Peng J, Lu L, Kaczorowski CC, Bryant CD, Homanics GE, Williams RW. Identification of a Functional Non-coding Variant in the GABA A Receptor a2 Subunit of the C57BL/6J Mouse Reference Genome: Major Implications for Neuroscience Research. Front Genet. 2019; 10:188. PMID: 30984232; PMCID: PMC6449455; DOI: 10.3389/fgene.2019.00188;
-
Bryant CD, Bagdas D, Goldberg LR, Khalefa T, Reed ER, Kirkpatrick SL, Kelliher JC, Chen MM, Johnson WE, Mulligan MK, Imad Damaj M. C57BL/6 substrain differences in inflammatory and neuropathic nociception and genetic mapping of a major quantitative trait locus underlying acute thermal nociception. Mol Pain. 2019 Jan-Dec; 15:1744806918825046.View Related Profiles. PMID: 30632432; PMCID: PMC6365993; DOI: 10.1177/1744806918825046;
-
Babbs RK, Kelliher JC, Scotellaro JL, Luttik KP, Mulligan MK, Bryant CD. Genetic differences in the behavioral organization of binge eating, conditioned food reward, and compulsive-like eating in C57BL/6J and DBA/2J strains. Physiol Behav. 2018 12 01; 197:51-66. PMID: 30261172; PMCID: PMC6333425; DOI: 10.1016/j.physbeh.2018.09.013;
-
Ruan QT, Yazdani N, Beierle JA, Hixson KM, Hokenson KE, Apicco DJ, Luttik KP, Zheng K, Maziuk BF, Ash PEA, Szumlinski KK, Russek SJ, Wolozin B, Bryant CD. Changes in neuronal immunofluorescence in the C- versus N-terminal domains of hnRNP H following D1 dopamine receptor activation. Neurosci Lett. 2018 09 25; 684:109-114.View Related Profiles. PMID: 30003938; PMCID: PMC6330092; DOI: 10.1016/j.neulet.2018.07.015;
-
Apicco DJ, Ash PEA, Maziuk B, LeBlang C, Medalla M, Al Abdullatif A, Ferragud A, Botelho E, Ballance HI, Dhawan U, Boudeau S, Cruz AL, Kashy D, Wong A, Goldberg LR, Yazdani N, Zhang C, Ung CY, Tripodis Y, Kanaan NM, Ikezu T, Cottone P, Leszyk J, Li H, Luebke J, Bryant CD, Wolozin B. Reducing the RNA binding protein TIA1 protects against tau-mediated neurodegeneration in vivo. Nat Neurosci. 2018 01; 21(1):72-80.View Related Profiles. PMID: 29273772; PMCID: PMC5745051; DOI: 10.1038/s41593-017-0022-z;
-
Goldberg LR, Kirkpatrick SL, Yazdani N, Luttik KP, Lacki OA, Keith Babbs R, Jenkins DF, Evan Johnson W, Bryant CD. Casein kinase 1-epsilon deletion increases mu opioid receptor-dependent behaviors and binge eating1. Genes Brain Behav. 2017 Sep; 16(7):725-738.View Related Profiles. PMID: 28594147; PMCID: PMC6180211; DOI: 10.1111/gbb.12397;
-
Kirkpatrick SL, Goldberg LR, Yazdani N, Babbs RK, Wu J, Reed ER, Jenkins DF, Bolgioni AF, Landaverde KI, Luttik KP, Mitchell KS, Kumar V, Johnson WE, Mulligan MK, Cottone P, Bryant CD. Cytoplasmic FMR1-Interacting Protein 2 Is a Major Genetic Factor Underlying Binge Eating. Biol Psychiatry. 2017 May 01; 81(9):757-769.View Related Profiles. PMID: 27914629; PMCID: PMC5386810; DOI: 10.1016/j.biopsych.2016.10.021;
-
Young EE, Bryant CD, Lee SE, Peng X, Cook B, Nair HK, Dreher KJ, Zhang X, Palmer AA, Chung JM, Mogil JS, Chesler EJ, Lariviere WR. Systems genetic and pharmacological analysis identifies candidate genes underlying mechanosensation in the von Frey test. Genes Brain Behav. 2016 Jul; 15(6):604-15. PMID: 27231153; PMCID: PMC4955286; DOI: 10.1111/gbb.12302;
-
-
-
Yazdani N, Parker CC, Shen Y, Reed ER, Guido MA, Kole LA, Kirkpatrick SL, Lim JE, Sokoloff G, Cheng R, Johnson WE, Palmer AA, Bryant CD. Hnrnph1 Is A Quantitative Trait Gene for Methamphetamine Sensitivity. PLoS Genet. 2015 Dec; 11(12):e1005713.View Related Profiles. PMID: 26658939; PMCID: PMC4675533; DOI: 10.1371/journal.pgen.1005713;
-
-
Zhou L, Bryant CD, Loudon A, Palmer AA, Vitaterna MH, Turek FW. The circadian clock gene Csnk1e regulates rapid eye movement sleep amount, and nonrapid eye movement sleep architecture in mice. Sleep. 2014; 37(4):785-93, 793A-793C. PMID: 24744456; PMCID: PMC3972422; DOI: 10.5665/sleep.3590;
-
Zhou L, Bryant CD, Loudon A, Palmer AA, Holz Vilaterna M, Turek FW. The circadian clock gene Csnk1e regulates rapid eye movement sleep amount, and nonrapid eye movement sleep architecture in mice. Sleep. 2014; 37(4):785-93. PMID: 25025121
-
Bryant CD, Guido MA, Kole LA, Cheng R. The heritability of oxycodone reward and concomitant phenotypes in a LG/J x SM/J F48 mouse advanced intercross line. Addiction Biology. 2014.
-
Bryant CD, Guido MA, Kole LA, Cheng R. The heritability of oxycodone reward and concomitant phenotypes in a LG/J?×?SM/J mouse advanced intercross line. Addict Biol. 2014 Jul; 19(4):552-61. PMID: 23231598; PMCID: PMC4300855; DOI: 10.1111/adb.12016;
-
Bryant CD, Kole LA, Guido MA, Cheng R, Palmer AA. Methamphetamine-induced conditioned place preference in LG/J and SM/J mouse strains and an F45/F46 advanced intercross line. Front Genet. 2012; 3:126. PMID: 22798962; PMCID: PMC3393886; DOI: 10.3389/fgene.2012.00126;
-
Bryant CD, Kole LA, Guido MA, Sokoloff G, Palmer AA. Congenic dissection of a major QTL for methamphetamine sensitivity implicates epistasis. Genes Brain Behav. 2012 Jul; 11(5):623-32. PMID: 22487465; PMCID: PMC3691852; DOI: 10.1111/j.1601-183X.2012.00795.x;
-
-
Bryant CD, Parker CC, Zhou L, Olker C, Chandrasekaran RY, Wager TT, Bolivar VJ, Loudon AS, Vitaterna MH, Turek FW, Palmer AA. Csnk1e is a genetic regulator of sensitivity to psychostimulants and opioids. Neuropsychopharmacology. 2012 Mar; 37(4):1026-35. PMID: 22089318; PMCID: PMC3280656; DOI: 10.1038/npp.2011.287;
-
Hofford RS, Hodgson SR, Roberts KW, Bryant CD, Evans CJ, Eitan S. Extracellular signal-regulated kinase activation in the amygdala mediates elevated plus maze behavior during opioid withdrawal. Behav Pharmacol. 2009 Oct; 20(7):576-83. PMID: 19738463; PMCID: PMC4494789; DOI: 10.1097/FBP.0b013e32832ec57e;
-
Bryant CD, Chang HP, Zhang J, Wiltshire T, Tarantino LM, Palmer AA. A major QTL on chromosome 11 influences psychostimulant and opioid sensitivity in mice. Genes Brain Behav. 2009 Nov; 8(8):795-805. PMID: 19694818; PMCID: PMC3697834; DOI: 10.1111/j.1601-183X.2009.00525.x;
-
Bryant CD, Roberts KW, Culbertson CS, Le A, Evans CJ, Fanselow MS. Pavlovian conditioning of multiple opioid-like responses in mice. Drug Alcohol Depend. 2009 Jul 1; 103(1-2):74-83. PMID: 19419821; PMCID: PMC3085957; DOI: 10.1016/j.drugalcdep.2009.03.016;
-
Bryant CD, Graham ME, Distler MG, Munoz MB, Li D, Vezina P, Sokoloff G, Palmer AA. A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology (Berl). 2009 May; 203(4):703-11. PMID: 19050854; PMCID: PMC2729782; DOI: 10.1007/s00213-008-1417-z;
-
Bryant CD, Zhang NN, Sokoloff G, Fanselow MS, Ennes HS, Palmer AA, McRoberts JA. Behavioral differences among C57BL/6 substrains: implications for transgenic and knockout studies. J Neurogenet. 2008; 22(4):315-31. PMID: 19085272; PMCID: PMC3697827; DOI: 10.1080/01677060802357388;
-
Gioiosa L, Chen X, Watkins R, Klanfer N, Bryant CD, Evans CJ, Arnold AP. Sex chromosome complement affects nociception in tests of acute and chronic exposure to morphine in mice. Horm Behav. 2008 Jan; 53(1):124-30. PMID: 17956759; PMCID: PMC2713052; DOI: 10.1016/j.yhbeh.2007.09.003;
-
Bryant CD, Roberts KW, Byun JS, Fanselow MS, Evans CJ. Morphine analgesic tolerance in 129P3/J and 129S6/SvEv mice. Pharmacol Biochem Behav. 2006 Dec; 85(4):769-79. PMID: 17196637; PMCID: PMC1905890; DOI: 10.1016/j.pbb.2006.11.012;
-
Bryant CD, Eitan S, Sinchak K, Fanselow MS, Evans CJ. NMDA receptor antagonism disrupts the development of morphine analgesic tolerance in male, but not female C57BL/6J mice. Am J Physiol Regul Integr Comp Physiol. 2006 Aug; 291(2):R315-26. PMID: 16601258
-
Bryant CD, Zaki PA, Carroll FI, Evans CJ. Opioids and Addiction: Emerging pharmaceutical strategies for reducing reward and opponent processes. Clinical Neuroscience Research. 2005; (5):103-115.
-
Lutfy K, Eitan S, Bryant CD, Yang YC, Saliminejad N, Walwyn W, Kieffer BL, Takeshima H, Carroll FI, Maidment NT, Evans CJ. Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors. J Neurosci. 2003 Nov 12; 23(32):10331-7. PMID: 14614092
-
Eitan S, Bryant CD, Saliminejad N, Yang YC, Vojdani E, Keith D, Polakiewicz R, Evans CJ. Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization. J Neurosci. 2003 Sep 10; 23(23):8360-9. PMID: 12967998
-
Wilson SG, Bryant CD, Lariviere WR, Olsen MS, Giles BE, Chesler EJ, Mogil JS. The heritability of antinociception II: pharmacogenetic mediation of three over-the-counter analgesics in mice. J Pharmacol Exp Ther. 2003 May; 305(2):755-64. PMID: 12606637
This graph shows the total number of publications by year, by first, middle/unknown,
or last author.
Year | Publications |
---|
2005 | 1 |
2014 | 1 |